Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Press Releases
ImpriMed Unveils Groundbreaking Cell-Sizing Method for High-Accuracy Feline Lymphoma Characterization in Veterinary Sciences
Business Wire
Learn More →
Presentations
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning
ASCO Breakthrough 2024
Learn More →
Scientific Publications
Prognostic Utility of the Flow Cytometry and Clonality Analysis Results for Feline Lymphomas
Veterinary Sciences
Learn More →
In the News
ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market
Pulse 2.0
Learn More →
In the News
New AI Tool Guides Canine Cancer Treatment
Today's Veterinary Business
Learn More →
In the News
Artificial intelligence poised to transform veterinary care
AVMA News
Learn More →
In the News
New AI service offers personalized drug response predictions for canine patients with cancer
DVM360
Learn More →
Press Releases
ImpriMed Launches Innovative AI-Driven Drug Response Predictions (DRP) Service to Guide Tailored Treatments, Meet Rising Demand in Veterinary Oncology
Business Wire
Learn More →
Presentations
Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models
Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Learn More →
Press Releases
ImpriMed to Showcase Groundbreaking AI Research and Applications at Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Business Wire
Learn More →
Presentations
Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results
World Veterinary Cancer Congress 2024
Learn More →
Presentations
Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support
World Veterinary Cancer Congress 2024
Learn More →
Press Releases
ImpriMed to Present Innovative Research at 2024 World Veterinary Cancer Congress
Business Wire
Learn More →
Scientific Publications
Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma
Frontiers in Oncology
Learn More →
Presentations
AI-driven Personalized Medicine for Cancer Care
Precision Medicine World Conference 2024
Learn More →
In the News
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
TechCrunch
Learn More →
Press Releases
ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology
Business Wire
Learn More →
Presentations
Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results
65th ASH Annual Meeting and Exposition
Learn More →
Previous
Next
Webflow Homepage
Veterinary Precision Medicine
Human Precision Medicine
Ex Vivo CRO Services for Pharma
About Us
Careers
Events
Press
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Contact Us
